Status:
UNKNOWN
Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECG
Lead Sponsor:
Alexandrovska University Hospital
Conditions:
Coronary Ischemia
Eligibility:
All Genders
18-100 years
Brief Summary
After PCI searching for target lesion ischemia with intracoronary ECG will be performed and if found it will be treated pharmacologically
Detailed Description
The study will include patients with coronary lesions and PCI. It will include patients with stable or unstable angina, without elevated hs-TnT. PCI will be performed and monitoring of intracoronary S...
Eligibility Criteria
Inclusion
- Subject at least 18 years of age.
- Target lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. If there is side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
- Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.
Exclusion
- Subjects with significant ST-T change (≥ 1mm).
- Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
- Subjects who refuse to give informed consent.
- Subjects with the following angiographic characteristics: left main coronary artery stenosis, total occlusion target lesion, lesion of interest located at infarct-related artery.
- Subjects with LVEF \< 30%.
- Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy.
- LBBB, RBBB, atrial fibrillation/flutter with no identifiable isoelectric line.
Key Trial Info
Start Date :
January 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 5 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03383393
Start Date
January 3 2018
End Date
December 5 2019
Last Update
December 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandrovska University Hospital
Sofia, Bulgaria, 1413